In invasive carcinoma, the number of Mb-negative cases was markedly higher than in normal tissue: 29% were negative, 32% were weakly positive, 30% were moderately positive (Figure 1E) and 9% were strongly positive (Figure 1F). The gene discussed is MB; the disease is invasive carcinoma.